Like-For-Like Changes: Is Validation Testing Needed? Validation Case Study #7
|
|
- Peter Dalton
- 8 years ago
- Views:
Transcription
1 Paul L. Pluta] Like-For-Like Changes: Is Validation Testing Needed? Validation Case Study #7 Paul L. Pluta Validation Case Studies discusses validation situations useful to practitioners in validation and compliance. Each case presented deals with a specific validation problem, elements of which are described to demonstrate strategy to solve validation problems. We intend this column to be a useful resource for daily work applications. Reader comments, questions, and suggestions are needed to help us fulfill our objective for this column. Please send your comments and suggestions to managing editor Susan Haigney at shaigney@advanstar.com. KEY POINTS DISCUSSED The following key points are discussed: Change control is a critical activity in regulated pharmaceutical manufacturing. Changes to manufacturing processes, formulations, equipment, cleaning procedures, analytical methods, and other systems are evaluated based on risk or impact. Appropriate validation or qualification work is then prescribed. Like-for-like changes are usually considered to be minimal changes not requiring confirmatory validation testing. This discussion addresses situations in which likefor-like changes did not perform as expected due to incorrect installation of the replacement equipment. Several actual occurrences are described. Faulty installation of like-for-like equipment resulted in serious consequences for the manufacturing site. The site validation approval committee (VAC) should evaluate all changes, including like-for-like changes, to standardize evaluation and decision processes, and to carefully consider associated risks. Emergency changes may be approved as needed by maintenance or other management. However, these changes should ultimately be reviewed by the VAC for final disposition. Documentation attesting to correct installation of high-risk, like-for-like equipment can be accomplished by simple approved memo. This approach provides certainty of successful installation while reducing burdensome documentation requirements. Engineering and maintenance activities should have clear and defined procedures for like-for-like equipment replacement. Personnel should be cautioned against cutting corners due to business pressures. Validation and compliance personnel should be wary of supposed inconsequential like-for-like changes and ensure that such equipment in highrisk applications is properly installed including appropriate documentation. For more Author information, go to gxpandjvt.com/bios [ABOUT THE AUTHOR Paul L. Pluta, Ph.D., is a pharmaceutical scientist with extensive technical and management experience in the pharmaceutical industry. He is also adjunct assistant professor at the University of Illinois at Chicago (UIC) College of Pharmacy in Chicago, Illinois USA. He may be contacted by at paul.pluta@comcast.net. gxpandjvt.com Journal of Validation Technology [Spring 2011] 73
2 INTRODUCTION Change control is a critical component in regulated pharmaceutical manufacturing and quality systems. Changes to manufacturing processes, formulations, equipment, cleaning procedures, analytical methods, and other systems are evaluated based on risk or impact. Complicating these judgments are emergency situations when changes must be made to maintain operations without proactive thorough evaluation of risk or impact. Risk evaluation of change is a critical determination. At one extreme, changes may be significant representing a high risk to continuing critical processing or other operations. Such changes require full validation or qualification. At the other extreme, changes may be completely insignificant with minimal risk to patient, product, process, or equipment. Like-for-like changes are often judged to be changes in this latter category. Like-for-like changes are minimal changes made to processes, equipment, utilities, facilities, computers, or other systems. Like-for-like changes are usually judged to be equivalent replacements. Often these changes are identical replacements of the original item of interest. Some may not consider like-for-like changes to be an actual change. A replacement motor, replacement screen, replacement filter bag, replacement piping, and so on are often routine maintenance on validated or qualified equipment, and not really an actual change. Like-for-like changes are thought to not require any subsequent testing. Typical logic is that because the original equipment or system has already been validated, and because nothing has really changed, why the need to do new validation work? Why waste time or effort when nothing has changed? Isn t that the problem with validation doing too much unnecessary work? This discussion addresses situations in which like-forlike changes did not perform as expected. Several validation managers presented examples of such situations at international validation conferences. The occurrences described are actual incidents. Examples described demonstrate the broad scope and significant magnitude of potential problems with like-for-like changes. The following discussion includes: Background. The typical validation or qualification process is described. Compliance events. Descriptions of several actual like-for-like validation events. What are the issues? What happened to cause these problems? Corrective action and preventive action (CAPA). Recommended actions and improvements to prevent future problem occurrences. BACKGROUND The process of validation or qualification typically comprises the following sequence of activities: 1. Change desired. A new product or process, process change, or equipment change is needed or required. This may be a necessary change, a desirable improvement, emergency work, or routine maintenance. 2. Support pre-work. Appropriate pre-work is completed in advance and supporting the change. This work may range from highly complex and far-reaching (e.g., new process development, new equipment purchase, factory acceptance testing), to very minimal (e.g., selecting and ordering a minor replacement part). 3. Validation or change request. A formal request to initiate the validation process is submitted to the validation approval committee (VAC). Support work reports may be included in the request in support of the change. The change request may include a proposed level of work to confirm the acceptability of the change. The level of work is based on risk to the patient and to the organization. The VAC approves the validation request. 4. Validation plan. Depending on the scope and magnitude of the validation request, a validation plan may be submitted. This plan describes the validation work required in greater detail, appropriate testing and sampling proposed to demonstrate a successful change, and acceptance criteria for the recommended testing. The VAC approves the validation plan. 5. Validation protocol. A protocol is written specifying detailed sampling and testing to confirm the acceptability of the change. The VAC approves the validation protocol. 6. Validation work. Validation work is performed according to the protocol. Sampling and testing are completed. Data and other results are generated and recorded. 7. Validation report. A report containing all test results with discussion and conclusions is prepared and submitted to the VAC for approval. The report is approved, and the process or equipment change is implemented. An appropriate level of post-validation monitoring is proposed in the report. 8. Validation closure. If no other work is needed, the validation project initiated by the change request is closed. 74 Journal of Validation Technology [Spring 2011] ivthome.com
3 Paul L. Pluta. 9. Emergency changes. In cases of emergency changes, management may authorize changes to be completed as needed apart from the abovedescribed process. Emergency changes should be evaluated by the VAC as soon as possible. Supporting documentation is then completed to confirm the acceptability of the change and submitted to the VAC for approval. 10. Documentation. All relevant documentation described (activities 2-9) including supporting pre-work should be stored in the validation library or readily accessible through a knowledge management system. 11. Continued verification. Post-validation monitoring confirming acceptability of the change continues throughout the lifecycle. The issue addressed in this case study occurred in step number three, the validation or change request, which initiates the formal documented validation process. Emergency changes may also have application in this discussion. Specifically, changes requested were judged to be like-for-like changes that should have had no impact on the process or equipment. Because no impact was expected, no testing or other work was recommended by the VAC (or by management) as part of the change. Like-for-like replacement work was authorized and completed. Work was documented on equipment history logs, maintenance records, or other systems in accordance with site procedures. VALIDATION EVENTS A discussion with several validation managers regarding problems with validation activities indicated that like-for-like changes were a recurring problem. In general, changes are defined as like-for-like to eliminate additional validation work. The definition of like-forlike may be broadly interpreted in these cases and in some cases, too broadly interpreted. Occasionally, these judgments and ensuing problems had significant consequences. Several actual examples described by managers demonstrated such events. Personnel responsible for these like-for-like judgments did not realize the potential problems caused by their judgments. Laminar Air Flow in Aseptic Processing Facility One manager described an incident in which routine revalidation of an aseptic filling line was being performed. All activities and tests were performed according to procedure, including sterilizer revalidation, media runs, interventions, and so on. All results were acceptable and as expected until the filling line smoke test was conducted. The smoke test confirms the laminar airflow direction in the aseptic suite. All involved were shocked when the airflow was shown to be upward toward the HEPA filter instead of downward through the filter toward open product. Room and equipment history records were checked. The only activity performed in the area that could have caused this event was the installation of a like-for-like replacement blower motor by the site maintenance shop several months prior. HEPA filtration of room air had thus been compromised for several months, during which time multiple product lots were manufactured. These lots had passed all product testing and were released to commercial distribution. The US Food and Drug Administration was notified. All lots manufactured during the time period when the blower motor was operating incorrectly were recalled. Aside from this incident being highly embarrassing to the organization, the recall costs involved were significant. Milling Solids for Tablet Products Another manager described an incident in which major processing problems with several tablet products occurred. This event occurred in a large manufacturing facility that produced multiple solid dosage forms (e.g., tablets, capsules, granules, powders). Occasional product processing problems were observed with several products. As these individual incidents became more frequent, investigations were initiated. The problem was eventually associated with particle size distribution changes. Blended granulations had smaller particle size distributions than expected when compared to historical data. Eventually these problems were associated with processing using a specific impact mill. When operation of the mill was investigated, it was found that the mill was running in the reverse direction compared to other mills at the site. This caused incorrect milling of solids and improper particle size distributions. Equipment history records were reviewed. The only activity performed that could have caused this event was the installation of a like-for-like replacement motor. The motor change was correlated to the first report of process problems at the site. Problems were associated with milling of large quantities of drug and inactive ingredients for respective lots. gxpandjvt.com Journal of Validation Technology [Spring 2011] 75
4 Cell Culture Agitation Another validation manager described an event in which the cell growth in a biotechnology process was significantly lower than the historical average when cultures were grown in a specific manufacturing tank. Because this product was a high volume product that was made in multiple tanks, the lower growth was not immediately obvious. As more low growth batches were manufactured, it became apparent that low yields were being consistently produced in a single tank. Equipment history records for the suspect tank were reviewed. The only work performed on the tank as documented in the equipment history log was the installation of a replacement motor on the mixer. The motor change was correlated to the first report of lowered growth and subsequent batches thereafter. When operation of the tank was thoroughly investigated, it was found that the impeller was running in the reverse direction compared to the original installation and compared to other tanks at the site. This effect significantly altered the mixing profile of the cell culture, resulting in reduced cell growth and active pharmaceutical ingredient yield. WHAT ARE THE ISSUES? In each of the events presented, a like-for-like change was performed without need for any confirmatory testing. Identical replacement equipment was available for each of the changes. All personnel involved believed that installation of replacement equipment was inconsequential and would be done correctly. The problems observed were completely unexpected. In each case, the like-for-like change was considered to be insignificant. Additional testing to verify acceptable equipment installation was not prescribed. Although the like-for-like equipment selection was accurate and acceptable, installation of the equipment was not. Faulty installation resulted in serious consequences for the manufacturing site and the organization. In the aseptic HEPA filter incident, a significant recall of product released to the marketplace was required. CORRECTIVE AND PREVENTIVE ACTIONS The incidents presented herein caused each validation manager to make changes in the change control review process at their respective manufacturing sites. Some of their comments and suggested approaches are described as follows. Validation Approval Committee Review of All Changes Validation managers agreed that all changes, including like-for-like changes, should ultimately be evaluated by the site VAC. Having all changes reviewed by a single responsible group (VAC) standardizes evaluation and decision processes. Consideration for risk to patient and organization and ensuing judgments should be uniformly conducted by the VAC. Appropriate confirmation that like-for-like equipment is properly installed would then be based on VAC judgment. In many cases, additional confirmatory work would not be required. For example, verification of a correctly-installed replacement conveyor belt motor is not necessary; if the motor was installed incorrectly and the conveyor is going backwards, the problem would be easily observed. The only like-for-like changes requiring verification are those in which installation errors would not be obvious during operation (e.g., reversed laminar air flow). In some organizations, maintenance management has the final and complete authority to judge whether or not validation of a change under their auspices is required. This practice should be limited to initiation of emergency changes only. If a change is like-for-like in the judgment of maintenance management, the emergency work should be initiated as soon as possible. Work should then be documented in equipment history logs or other site documentation systems. Completed emergency changes should then be evaluated by the site VAC. Completed changes are then evaluated based on work done and risk to patient and organization. Appropriate confirmatory work would then be prescribed. Maintenance management should be permitted to authorize emergency changes. All changes ultimately should be reviewed, evaluated, and judged by the site VAC. The VAC judgments are documented in the usual manner. Acceptability of changes is the ultimate responsibility of the VAC. Validation Documentation Requirements Protocols should not always be required to confirm acceptability of a like-for-like installation. A simple written memo with appropriate review and approval attesting to correct installation of replacement equipment should be sufficient to complete the work. The memo should include a statement that correct equipment operation had been confirmed by a second individual. Management of the responsible group (e.g., maintenance, engineering, others) and the site quality assurance (QA) department should approve 76 Journal of Validation Technology [Spring 2011] ivthome.com
5 Paul L. Pluta. the memo. The approved memo would then be filed with the validation request to close the like-for-like activity. This documentation approach accomplishes the need to verify high-risk installation without the encumbrance of validation protocols, excessive approvals, and other burdens. Some managers have successfully implemented this approach for certain high-risk changes. No additional verification documentation (other than equipment history, etc.) was required for insignificant like-for-like changes or for changes in which correct installation was apparent by obvious faulty equipment operation. Procedures and Training The above approaches to decision-making and documentation should be specified in approved procedure. Specifying the acceptability of such confirmatory documentation provides flexibility to accomplish verification without the burden of excessive protocol requirements. All associated individuals in technical functions, validation personnel, maintenance management, VAC members, and QA personnel should be trained on the new procedure. Equipment Installation and Maintenance Procedures Validation managers commented that engineering and maintenance areas must have clear procedures for like-for-like equipment replacement. Procedures must be maintained and strengthened as needed when incidents occur. New personnel should be made aware of events such as those presented herein and be cautioned about cutting corners. Business and operation pressures often demand rapid work from these groups. Personnel must understand that proper equipment installation must never be potentially compromised. Senior Management Support Validation managers reported that their respective site senior management was supportive of the above approaches. Validation managers reported no similar faulty installation incidents after implementation of the new verification procedure. CONCLUSIONS This case study describes several examples of improper installation of like-for-like equipment that caused significant problems for the manufacturing site. Likefor-like changes are generally assumed to be of no consequence. However, improper installation of such equipment can have serious ramifications including product recalls. Validation managers agreed that all changes, including like-for-like changes, should be evaluated by the site VAC to standardize evaluation and decision processes. Documentation requirements attesting to correct installation of high-risk, like-for-like equipment can be accomplished by a simple approved memo that is filed with the documentation request. This approach provides certainty of successful installation without undue documentation burden. Engineering and maintenance procedures for like-for-like equipment replacement must be clear. Validation and compliance personnel should be wary of supposed inconsequential like-for-like changes and ensure that such equipment in high-risk applications is properly installed. JVT gxpandjvt.com Journal of Validation Technology [Spring 2011] 77
Compliance Case Study #3 Manual Processes, Performance, Responsibilities, and Training
Compliance Case Study #3 Manual Processes, Performance, Responsibilities, and Training Paul L. Pluta, Timothy J. Fields, and Alan J. Smith IMAGEZOO/GETTY IMAGES Compliance Case Studies discusses compliance
More information[ABOUT THE AUTHOR. FDA Lifecycle Approach to Process Validation What, Why, and How? PQ Forum. Paul L. Pluta]
Paul L. Pluta] FDA Lifecycle Approach to Process Validation What, Why, and How? Paul L. Pluta PQ Forum provides a mechanism for validation practitioners to share information about Stage 2 process qualification
More informationQualification of an Environmental Monitoring Program
[ Scott Sutton Qualification of an Environmental Monitoring Program Scott Sutton Microbiology Topics discusses various topics in microbiology of practical use in validation and compliance. We intend this
More information11.I In-process control Authors: Dr. Christian Gausepohl / Paolomi Mukherji / Update 07
In-process control In-process control Authors: Dr. Christian Gausepohl / Paolomi Mukherji / Update 07 Here you will find answers to the following questions: What are the in-process control tasks? Where
More informationGMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE OF STERILE MEDICINAL PRODUCTS
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 032-2 8 January 2010 RECOMMENDATION GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE
More informationCommercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations
Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Kevin O Donnell PhD Market Compliance Manager, IMB PDA / FDA Conference Pharmaceutical
More informationA SUGGESTED HARMONIZATION OF DMAIC WITH PMBOK PROJECT LIFE CYCLES FOR PHARMACEUTICAL LEAN SIX SIGMA PROJECTS
Abstract: With the increased emphasis within the pharmaceutical industry on business productivity through the dual application of Lean Six Sigma and disciplined project management methodologies, there
More informationAnnex 7 Guidelines on pre-approval inspections
World Health Organization WHO Technical Report Series, No. 902, 2002 Annex 7 Guidelines on pre-approval inspections 1. General 94 2. Glossary 94 3. Objectives 95 4. Priorities 96 5. Preparation for the
More informationPosition Classification Standard for Pharmacy Technician Series, GS-0661
Position Classification Standard for Pharmacy Technician Series, GS-0661 Table of Contents SERIES DEFINITION... 2 SERIES COVERAGE... 2 EXCLUSIONS... 4 TITLES... 4 NOTES TO USERS OF THIS STANDARD... 5 CLASSIFICATION
More informationSmoke Studies: Clearing the Mystery of Air Flow Visualization
Ed White, Coordinator] Smoke Studies: Clearing the Mystery of Air Flow Visualization Steven Klingenberg The Aseptic Core discusses scientific and regulatory considerations for aseptic processing, with
More informationUW School of Dentistry Comprehensive Medication Policy
UNIVERSITY OF WASHINGTON SCHOOL OF DENTISTRY Subject: UW School of Dentistry Comprehensive Medication Policy Policy Number: Effective Date: December 2014 Revision Dates: June 2015 PURPOSE This policy provides
More informationThe following Good Compounding Practices (GCPs) are meant to apply only to the compounding of drugs by State-licensed pharmacies.
1 NABP Model State Pharmacy Act & Model Rules Appendix B Good Compounding Practices Applicable to State Licensed Pharmacies The following Good Compounding Practices (GCPs) are meant to apply only to the
More information- 1 - First Time Pharmacy Managers (Revised 02/02/2011)
State of Connecticut Department of Consumer Protection Commission of Pharmacy 165 Capitol Avenue, Room 147 Hartford, CT 06106 - Telephone: 860-713-6070 ALL FIRST-TIME PHARMACY MANAGERS ARE REQUIRED TO
More informationDraft guidance for registered pharmacies preparing unlicensed medicines
Draft guidance for registered pharmacies preparing unlicensed medicines January 2014 1 The General Pharmaceutical Council is the regulator for pharmacists, pharmacy technicians and registered pharmacies
More information[See Rules 74,74-A, 74-B, 78 and 78-A] A. SUBSTANCES OTHER THAN PARENTERAL IN PREPARATIONS IN GENERAL
29 [SCHEDULE U [See Rules 74,74-A, 74-B, 78 and 78-A] I. Particulars to the shown in /manufacturing Records A. SUBSTANCES OTHER THAN PARENTERAL IN PREPARATIONS IN GENERAL 1. Serial number. 2. Name of the
More informationLibrary Guide: Pharmaceutical GMPs
Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA
More informationPROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)
January 2013 RESTRICTED PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) DRAFT FOR COMMENTS Please address any comments on this proposal
More informationHow single-use connections advance aseptic processing: Increased process flexibility and reliability, reduced costs
WHITE PAPER 7004 How single-use connections advance aseptic processing: Increased process flexibility and reliability, reduced costs By John Boehm Business Unit Manager Colder Products Company Today s
More informationFDA and the Compounding Pharmacy
FDA and the Compounding Pharmacy Scott Sutton, Ph.D. scott.sutton@microbiol.org 41 Overview of Presentation The Recent Events GCP and GMP Basics the 483 Review H.R. 3204 Outsourcing Facility Preparation
More informationPharmaceutical Quality Systems: US Perspective
Pharmaceutical Quality Systems: US Perspective Rick Friedman Associate Director, Office of Manufacturing and Product Quality Center for Drug Evaluation and Research Topics Background: The ICH Q10 Pharmaceutical
More informationEDUCATOR S LESSON PLAN
EDUCATOR S LESSON PLAN Pharmacy Technician Training Program Student Version Orientation Orientation introduces the student to basic terms and definitions. An introduction to the Pharmacy Technician Certification
More informationChanges to an Approved Product
Changes to an Approved Product Chemistry, Manufacturing and Controls By Khandan Baradaran, PhD and Peggy Berry, MBA, RAC It is a huge achievement for any company to obtain licensing rights to an approved
More informationITIL: Service Operation
ITIL: Service Operation Course Course Chapter 01 - Course Lesson: Course Organization Welcome to the Course! Mentoring Community s Why Are You Here? Using Bloom s Taxonomy What do you Expect? Housekeeping
More informationREAL-TIME INTELLIGENCE FOR FASTER PATIENT INTERVENTIONS. MICROMEDEX 360 Care Insights. Real-Time Patient Intervention
REAL-TIME INTELLIGENCE FOR FASTER PATIENT INTERVENTIONS MICROMEDEX 360 Care Insights Real-Time Patient Intervention Real-Time Intelligence for Fast Patient Interventions At your patient s side, developments
More informationCORPORATE QUALITY MANUAL
Corporate Quality Manual Preface The following Corporate Quality Manual is written within the framework of ISO 9001:2008 Quality System by the employees of CyberOptics. CyberOptics recognizes the importance
More informationLevel 2 Certificate in Pharmaceutical Science (5356-02)
Level 2 Certificate in Pharmaceutical Science (5356-02) Qualification handbook for centres 500/9575/4 www.cityandguilds.com September 2010 Version 1.0 About City & Guilds City & Guilds is the UK s leading
More informationWorking Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 Working Party on Control
More informationA Collaboration of Senior Design Projects with Industry
A Collaboration of Senior Design Projects with Industry Duane Swigert Metropolitan State University of Denver Abstract The senior project class is a two semester sequence open to those students who have
More informationFundamentals of Tablet Compression
PHARMACEUTICAL PROCESSES Fundamentals of Tablet Compression Armin H. Gerhardt GLOWIMAGES/GETTY IMAGES Pharmaceutical Processes discusses scientific and technical principles associated with pharmaceutical
More informationCorrective and Preventive Actions
Corrective and Preventive Actions A Five Step Approach Topics to Be Covered What is CAPA? Governing authority Five steps to a good CAPA process Where companies have difficulty Example citations Recap What
More informationA NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program
A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry PROJECT MANAGEMENT: RENOVATION OF RESEARCH LABORATORY FOR CELL CULTURE
More informationChoosing the right enterprise resource
whitepaper Choosing the right enterprise resource Planning (ERP) System How to Avoid the 7 Fatal Flaws WHITEPAPER Choosing the Right ERP System 2 about For process manufacturers like chemicals, pharmaceuticals
More informationAsbestos in the Workplace: A Guide to Removal of Friable Asbestos Containing Material
Asbestos in the Workplace: A Guide to Removal of Friable Asbestos Containing Material Revised November 21, 2013 Application Code of Practice Where asbestos is present or believed to be present in a workplace
More informationSpecifications For Rehabilitation Hudson #1A Hudson #2 Foster Island Well #41
Specifications For Rehabilitation Hudson #1A Hudson #2 Foster Island Well #41 ITEM #6 1) Scope of Work The scope of this proposal is: Hudson Street Well #1A and Hudson Street Well #2 - clean and rehabilitate,
More informationJANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS
JANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS 1 WHAT IS A SITE MASTER FILE? A Site Master File (SMF) is a document prepared by the manufacturer containing specific
More informationHaulsey Engineering, Inc. Quality Management System (QMS) Table of Contents
Haulsey Engineering, Inc. Quality Management System (QMS) Table of Contents 1.0 Introduction 1.1 Quality Management Policy and Practices 2.0 Quality System Components 2.1 Quality Management Plans 2.2 Quality
More informationPharmacy Technician Structured Practical Training Program MANUAL AND SUBMISSION FORMS. December 2014 (Updated July 2015)
Pharmacy Technician Structured Practical Training Program MANUAL AND SUBMISSION FORMS December 2014 (Updated July 2015) *To be reviewed by Supervisor and Pharmacy Technician-in-Training and used in conjunction
More informationConducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.
Conducting a Gap Analysis on your Change Control System Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Standards, Regulations, Guidelines related to Change Control Management
More informationGuidance for Industry. Q10 Pharmaceutical Quality System
Guidance for Industry Q10 Pharmaceutical Quality System U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation
More informationGeneral Guidance for Developing, Documenting, Implementing, Maintaining, and Auditing an SQF System. Module 2: System Elements. SQF Code, Edition 7.
General Guidance for Developing, Documenting, Implementing, Maintaining, and Auditing an SQF System Module 2: System Elements SQF Code, Edition 7.1 M A Y 2 0 1 3 2013 Safe Quality Food Institute 2345 Crystal
More informationWorking Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice
Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 S\common\legal-legislation\75-319nd81-851\91-356\eudralexvol4\Annex
More informationPUBLIC HEALTH OPTOMETRY ECONOMICS. Kevin D. Frick, PhD
Chapter Overview PUBLIC HEALTH OPTOMETRY ECONOMICS Kevin D. Frick, PhD This chapter on public health optometry economics describes the positive and normative uses of economic science. The terms positive
More informationCalibration & Preventative Maintenance. Sally Wolfgang Manager, Quality Operations Merck & Co., Inc.
Calibration & Preventative Maintenance Sally Wolfgang Manager, Quality Operations Merck & Co., Inc. Calibration: A comparison of two instruments or measuring devices one of which is a standard of known
More informationISO 9001 Quality Management Systems Professional
ISO 9001 Quality Management Systems Professional Professional Certifications Sample Questions Sample Questions 1. The non-fulfillment of a specified requirement is called a: A. Concession B. Nonconformity
More informationHow To Get A Prescription In Rhode Island
Controlled Substance Prescribing Laws, The Prescription Monitoring Program, and Preventing Drug Diversion Michael Halse, PharmD PGY1 Resident Pharmacist South County Hospital and Healthcare System Disclosures
More informationMultiple Products in a Monoclonal Antibody S88.01 Batch Plant
Presented at the World Batch Forum North American Conference Chicago, IL May 16-19, 2004 900 Fox Valley Drive, Suite 204 Longwood, FL 32779-2552 +1.407.774.0207 Fax: +1.407.774.6751 E-mail: info@wbf.org
More informationProfessional Engineers Using Software-Based Engineering Tools
GUIDELINE Professional Engineers Using Software-Based Engineering Tools CONTRIBUTORS Eric Brown, P. Eng. Colin Cantlie, P. Eng. Norm Fisher, P. Eng. Jeremy Jackson, P. Eng. Tibor Palinko, P. Eng. Daniel
More informationPHARMACEUTICAL QUALITY SYSTEM Q10
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE PHARMACEUTICAL QUALITY SYSTEM Q10 Current Step
More informationGUIDELINES FOR NUCLEAR PHARMACY TECHNICIAN TRAINING PROGRAMS
GUIDELINES FOR NUCLEAR PHARMACY TECHNICIAN TRAINING PROGRAMS Prepared by Ad Hoc Committee on Nuclear Pharmacy Technicians Nuclear Pharmacy Section Academy of Pharmacy Practice and Management American Pharmaceutical
More informationHow To Audit A Company
INTERNATIONAL STANDARD ON AUDITING 315 IDENTIFYING AND ASSESSING THE RISKS OF MATERIAL MISSTATEMENT THROUGH UNDERSTANDING THE ENTITY AND ITS ENVIRONMENT (Effective for audits of financial statements for
More informationProcess Validation Guidance Requirements (FDA and EU Annex 15: Qualification and Validation)
Global CompliancePanel Knowledge, a Way Forward 2-day In-person Seminar: Process Validation Guidance Requirements (FDA and EU Annex 15: Qualification and Validation) Los Angeles, CA July 28th & 29th, 2016
More informationProcess Validation: Practical Aspects of the New FDA Guidance
Process Validation: Practical Aspects of the New FDA Guidance ISPE Boston Chapter Meeting April 18, 2013 Rusty Morrison Commissioning Agents, Inc. Objectives / Summary What is Process Validation? Regulatory
More informationRisk Assessment for Medical Devices. Linda Braddon, Ph.D. Bring your medical device to market faster 1
Risk Assessment for Medical Devices Linda Braddon, Ph.D. Bring your medical device to market faster 1 My Perspective Work with start up medical device companies Goal: Making great ideas into profitable
More informationSimulation and Optimisation of a Pharmaceutical Production Line
International Journal of Emerging Engineering Research and Technology Volume. 2, Issue 6, September 2014, PP 64-71 ISSN 2349-4395 (Print) & ISSN 2349-4409 (Online) Simulation and Optimisation of a Pharmaceutical
More informationFood and Drug Administration, HHS Pt. 212
erowe on DSK2VPTVN1PROD with CFR Food and Drug Administration, HHS Pt. 212 investigation was found not to be necessary and the name of the responsible person making such a determination. [43 FR 45077,
More informationLocal Enhanced Service Specification for the Supply of Pharmaceutical Services to Care Homes through Community Pharmacy
Local Enhanced Service Specification for the Supply of Pharmaceutical Services to Care Homes through Community Pharmacy Contents: 1. Introduction and purpose 2. Period of Service 3. Aim of the Service
More informationISO 9001 Quality Systems Manual
ISO 9001 Quality Systems Manual Revision: D Issue Date: March 10, 2004 Introduction Micro Memory Bank, Inc. developed and implemented a Quality Management System in order to document the company s best
More information03 PHARMACY TECHNICIANS
03 PHARMACY TECHNICIANS 03-00 PHARMACY TECHNICIANS REGISTRATION/PERMIT REQUIRED 03-00-0001 DEFINITIONS: A. PHARMACY TECHNICIAN: This term refers to those individuals identified as Pharmacist Assistants
More informationPRODUCT DEVELOPMENT GUIDE
PRODUCT DEVELOPMENT GUIDE PRE-FORMULATION - TABLETS Introduction Guidelines for the development of a ANDA product for the US market, Note: some tests or procedures may be unnecessary. The order of performing
More informationAnnex 7 Application of Hazard Analysis and Critical Control Point (HACCP) methodology to pharmaceuticals
World Health Organization WHO Technical Report Series, No. 908, 2003 Annex 7 Application of Hazard Analysis and Critical Control Point (HACCP) methodology to pharmaceuticals 1. Introduction Traditionally,
More informationFDA Title 21 CFR Part 11:Electronic Records; Electronic Signatures; Final Rule (1997)
www.qadata.co.za Introduction FDA Title 21 CFR Part 11:Electronic Records; Electronic Signatures; Final Rule (1997) INITIAL REGULATION RELEASED High profile audit findings Industry complaints to wasting
More informationQUALITY RISK MANAGEMENT (QRM): A REVIEW
Lotlikar et al Journal of Drug Delivery & Therapeutics; 2013, 3(2), 149-154 149 Available online at http://jddtonline.info REVIEW ARTICLE QUALITY RISK MANAGEMENT (QRM): A REVIEW Lotlikar MV Head Corporate
More informationENVIRONMENTAL MONITORING
ENVIRONMENTAL MONITORING Assessment and verification of the adequacy of the aseptic compounding environment is essential. Environmental monitoring programs are designed to promptly identify potential sources
More informationISO 9001:2008 STANDARD OPERATING PROCEDURES MANUAL
8200 Brownleigh Drive Raleigh, NC 27617-7423 Phone: (919) 510-9696 Fax: (919) 510-9668 ISO 9001:2008 STANDARD OPERATING PROCEDURES MANUAL ALLIANCE OF PROFESSIONALS & CONSULTANTS, INC. - 1 - Table of Contents
More informationGuidance for Industry
Guidance for Industry Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation
More informationcgmp Challenges for Cord Blood Banks
cgmp Challenges for Cord Blood Banks Donna M. Regan, MT(ASCP)SBB St. Louis Cord Blood Bank @ SSM Cardinal Glennon Children s s Medical Center Cord Blood Bank processing facility challenges What does cgmp
More informationCENTRIS CONSULTING. Quality Control Manual
CENTRIS CONSULTING Quality Control Manual ISO 9001:2008 Introduction Centris Consulting developed and implemented a Quality Management System in order to document the company s best business practices,
More informationGuidance for Industry
Guidance for Industry Q8, Q9, and Q10 Questions and Answers(R4) U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics
More informationGEA Niro Pharmaceutical GMP Spray Drying facility. Spray drying process development and contract manufacturing. engineering for a better world
GEA Niro Pharmaceutical GMP Spray Drying facility Spray drying process development and contract manufacturing engineering for a better world GEA Process Engineering 2 GEA Niro PSD-4 Chamber cone in clean
More informationWHEREAS, the City of Shavano Park wishes to clarify the procedures for the organization, maintenance, disposition and destruction of City Records;
RESOLUTION R-2015-024 A RESOLUTION ESTABLISHING POLICY FOR THE ORGANIZATION, MAINTENANCE, DISPOSITION AND DESTRUCTION OF CITY OF SHAVANO PARK RECORDS; AS CONSISTENT WITH THE REQUIREMENTS OF THE TEXAS LOCAL
More informationContract No: Disclaimer:
Contract No: This document was prepared in conjunction with work accomplished under Contract No. DE-AC09-09SR22505 with the U.S. Department of Energy (DOE) National Nuclear Security Administration (NA).
More informationAMENDED January 27, 2015
Proposed Language To Amend 1735 in Article 4.5 of Division 17 of Title 16 of the California Code of Regulations to read as follows: 1735. Compounding in Licensed Pharmacies. (a) Compounding means any of
More informationQuality Manual. UK Wide Security Solutions Ltd. 1 QM-001 Quality Manual Issue 1. January 1, 2011
Quality Manual 1 QM-001 Quality Manual Issue 1 January 1, 2011 This document is uncontrolled when printed. Please verify with Quality Management Representative 16 Dukes Close, West Way, Walworth Industrial
More informationCleaning validation of cleanrooms and preparation equipments
Cleaning validation of cleanrooms and preparation equipments Head of production Central Pharmacy, Geneva University Hospitals EAHP Foundation Seminar: Patient Safety; More About Compounding" 23-25 May,
More informationBREAK-EVEN ANALYSIS. In your business planning, have you asked questions like these?
BREAK-EVEN ANALYSIS In your business planning, have you asked questions like these? How much do I have to sell to reach my profit goal? How will a change in my fixed costs affect net income? How much do
More informationBill Mixon, RPh, MS Senior Associate Gates Healthcare Associates
Bill Mixon, RPh, MS Senior Associate Gates Healthcare Associates 14 pharmacists and 1 epidemiologist make up the committee USP staff FDA and CDC representatives have input but do not vote Call for Candidates
More informationA Preliminary Proposal for a Pharmaceutical Engineering Graduate Program
A Preliminary Proposal for a Pharmaceutical Engineering Graduate Program Planning Committee: Prabir Basu Steve Byrn Ken Morris Rex Reklaitis Paul Sojka Venkat Venkatasubramanian Carl Wassgren National
More informationVolkmann Vacuum Conveying Applications. Powder Handling in the Pharmaceutical Industry: A Case Study
Volkmann Vacuum Conveying Applications Powder Handling in the Pharmaceutical Industry: A Case Study w w w.volkmannusa.com Powder Handling in the Pharmaceutical Industry A Case Study VOLKMANN Inc. The correct
More informationMedia fills Periodic performance qualification (Re-Validation)
Media fills Periodic performance qualification (Re-Validation) Minimum number of Simulations Number of units Contaminated Units Action a Two per Year (Retrospective & Prospective Validation) < 5000 5000
More informationCustomized Nutritional Solutions For Laboratory Animals
A LT R O M I N Customized Nutritional Solutions For Laboratory Animals Dear Sir or Madam, we would like to thank you for a good and successful co-operation in 2008 and furthermore we wish you and your
More informationPHARMACY TECHNICIAN SERIES
PHARMACY TECHNICIAN SERIES Occ. Work Prob. Effective Last Code No. Class Title Area Area Period Date Action 4058 Pharmacy Technician I 12 446 6 mo. 02/15/04 Revised 4059 Pharmacy Technician II 12 446 6
More informationCONNECTICUT. Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION
CONNECTICUT Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION (d) General Conditions. (6) All medications shall be administered only by licensed
More informationPROCESS VALIDATION OF TABLETS: AN OVERVIEW
PROCESS VALIDATION OF TABLETS: AN OVERVIEW Vikas Verma 1*, Ujjwal Nautiyal 1, M. Senthil Kumar 1, Chandra Kant 1 1 Department of Pharmacy, Himachal institute of Pharmacy, Paonta Sahib, (H.P), India. ABSTRACT
More informationANDA CHECKLIST FOR CTD or ectd FORMAT FOR COMPLETENESS and ACCEPTABILITY of an APPLICATION FOR FILING
ANDA CHECKLIST FOR CTD or ectd FORMAT FOR COMPLETENESS and ACCEPTABILITY of an APPLICATION FOR FILING For More Information on Submission of an ANDA in Electronic Common Technical Document (ectd) Format
More informationDrug Supply Chain Security Act (Title II of the Drug Quality and Security Act) Overview and Implementation
Drug Supply Chain Security Act (Title II of the Drug Quality and Security Act) Overview and Implementation Connie Jung, RPh, PhD U.S. Food and Drug Administration NACDS Total Store Expo August 24, 2014
More informationSandoz Private Limited 10/22/15
Sandoz Private Limited 10/22/15 Department of Health and Human Services Public Health Service Food and Drug Administration Silver Spring, MD 20993 Warning Letter VIA UPS WL: 320-16-01 October 22, 2015
More information- Table of Contents -
- Table of Contents - 1 INTRODUCTION... 1 1.1 TARGET READERS OF THIS DOCUMENT... 1 1.2 ORGANIZATION OF THIS DOCUMENT... 2 1.3 COMMON CRITERIA STANDARDS DOCUMENTS... 3 1.4 TERMS AND DEFINITIONS... 4 2 OVERVIEW
More information3.4.4 Description of risk management plan Unofficial Translation Only the Thai version of the text is legally binding.
- 1 - Regulation of Department of Industrial Works Re: Criteria for hazard identification, risk assessment, and establishment of risk management plan B.E. 2543 (2000) ---------------------------- Pursuant
More informationQuality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702
Quality Management System MANUAL SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702 Doc. No. G5500 Rev. 9.1 Status : APPROVED Effective: 12/11/2014 Page 2 of 23 Quality Manual Table of Contents
More informationAN INTRODUCTION TO PREMIUM TREND
AN INTRODUCTION TO PREMIUM TREND Burt D. Jones * February, 2002 Acknowledgement I would like to acknowledge the valuable assistance of Catherine Taylor, who was instrumental in the development of this
More informationWorkshop A Design Space (DS)
Implementation of ICH Q8, Q9, Q10 Workshop A Design Space (DS) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Disclaimer The information
More informationRisk Management for Aseptic Processing
Risk Management for Aseptic Processing Ed White Welcome to The Aseptic Core. This column discusses scientific and regulatory aspects of aseptic processing, with an emphasis on aseptic formulation and filling.
More informationA NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program
A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry CLEANING VALIDATION Instructors Loh Kean Chong Rick Ng Date and Time
More informationThrough Proper Testing Techniques. By Perry D. Drake
Through Proper Testing Techniques By Perry D. Drake Seminar Objectives In this lunch session we will discuss how a marketer utilizes a database to ensure maximum return on investment via proper test design
More informationUsing Evidence-Based Search Marketing to Improve Results and Reduce Costs
Using Evidence-Based Search Marketing to Improve Results and Reduce Costs January 2011 Using Evidence-Based Search Marketing to Improve Results and Reduce Costs Introduction The pace of research and innovation
More informationREGULATION (EEC) No 2309/93
REGULATION (EEC) No 2309/93 Council Regulation (EEC) No 2309/93 of 22 July 1993 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use
More informationICH guideline Q10 on pharmaceutical quality system
September 2015 EMA/CHMP/ICH/214732/2007 Committee for Human Medicinal Products Step 5 Transmission to CHMP May 2007 Transmission to interested parties May 2007 Deadline for comments November 2007 Final
More informationGUIDELINES FOR FOOD IMPORT CONTROL SYSTEMS
GUIDELINES FOR FOOD IMPORT CONTROL SYSTEMS SECTION 1 SCOPE CAC/GL 47-2003 1. This document provides a framework for the development and operation of an import control system to protect consumers and facilitate
More informationUnderstanding Manufacturing Execution Systems (MES)
Understanding Manufacturing Execution Systems (MES) Presented by: Shirley Schmidt Freedom Technologies 10370 Citation Dr., Suite 200 Brighton, MI 48116 Phone: 810-227-3737 www.freedomcorp.com What is a
More informationPREVIEW COPY. The picture is not clear. How many CCTV surveillance cameras in the UK? A study by the BSIA. July 2013. Form No. 195 Issue 1.
The picture is not clear How many CCTV surveillance cameras in the UK? A study by the BSIA July 2013 For other information please contact: British Security Industry Association t: 0845 389 3889 f: 0845
More information